Evidence map›Paper›PMID 38396407›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Impact of Epicardial Adipose Tissue on Infarct Size and Left Ventricular Systolic Function in Patients with Anterior ST-Segment Elevation Myocardial Infarction.

Jose Gavara, Hector Merenciano-Gonzalez, Jordi Llopis-Lorente, Tamara Molina-Garcia, Nerea Perez-Solé, Elena de Dios, Víctor Marcos-Garces, Jose V Monmeneu, Maria P Lopez-Lereu, Joaquim Canoves and 8 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Jose GavaraCenter for Biomaterials and Tissue Engineering, Universitat Politècnica de València, 46022 Valencia, Spain.ORCID 0000-0002-3483-7066
Hector Merenciano-GonzalezInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.ORCID 0000-0002-1734-0381
Jordi Llopis-LorenteCentro de Investigación e Innovación en Bioingeniería (Ci2B), Universitat Politècnica de València, 46010 Valencia, Spain.ORCID 0000-0002-3958-8062
Tamara Molina-GarciaInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.
Nerea Perez-SoléInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.ORCID 0000-0003-3527-0337
Elena de DiosCentro de Investigación Biomédica en Red-Cardiovascular (CIBER-CV), 28022 Madrid, Spain.
Víctor Marcos-GarcesInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.ORCID 0000-0001-5565-5547
Jose V MonmeneuCardiovascular Magnetic Resonance Unit, ASCIRES Biomedical Group, 46004 Valencia, Spain.
Maria P Lopez-LereuCardiovascular Magnetic Resonance Unit, ASCIRES Biomedical Group, 46004 Valencia, Spain.
Joaquim CanovesInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.
Clara BonanadInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.ORCID 0000-0001-8665-7107
David MoratalCenter for Biomaterials and Tissue Engineering, Universitat Politècnica de València, 46022 Valencia, Spain.ORCID 0000-0002-2825-3646
Julio NúñezInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.ORCID 0000-0003-1672-7119
Antoni Bayés-GenisCentro de Investigación Biomédica en Red-Cardiovascular (CIBER-CV), 28022 Madrid, Spain.
Juan SanchisInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.ORCID 0000-0003-0797-8709
Francisco J ChorroInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.
Cesar Rios-NavarroInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.ORCID 0000-0002-6405-6279
Vicente BodíInstituto de Investigación Sanitaria INCLIVA, 46010 Valencia, Spain.
Universitat de València · ESHospital Clínico Universitario de Valencia · ESINCLIVA Health Research Institute · ESUniversitat Politècnica de València · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESUniversitat Autònoma de Barcelona · ES

Funding

Agencia Estatal de Investigación FJC2020-043981-I/AEI/10.13039/501100011033Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital CIGE/2022/26, AEST/2021/050, CIAEST/2021/27Generalitat Valenciana PROMETEO/2021/008Instituto de Salud Carlos III PI20/00637, PI23/01150, CB16/11/00403, CB16/11/00420, CIBERCV16/11/00486, CM21/00175
6 · The paper itself

Abstract

We aimed to assess the correlation of cardiovascular magnetic resonance (CMR)-derived epicardial adipose tissue (EAT) with infarct size (IS) and residual systolic function in ST-segment elevation myocardial infarction (STEMI). We enrolled patients discharged for a first anterior reperfused STEMI submitted to undergo CMR. EAT, left ventricular (LV) ejection fraction (LVEF), and IS were quantified at the 1-week (

Indexed as

cardiovascular magnetic resonanceepicardial adipose tissueinfarct sizeleft ventricular ejection fractionST-segment elevation myocardial infarction

Identifiers

PMID38396407
PMCPMC10888463
OpenAlexW4391616909

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.